Phenoxymethylpenicillin: Penicillin V as an oral narrow spectrum antibiotic
Phenoxymethylpenicillin, referred to almost exclusively as Penicillin V in clinical practice, is the oral, acid stable variant of benzylpenicillin. It was introduced into clinical practice in 1953 and has since been one of the most frequently prescribed narrow spectrum antibiotics in outpatient medicine. Well known brand names include Isocillin, Megacillin oral, Penbeta and numerous generics.
Penicillin V is used selectively when a pathogen with high susceptibility to Beta lactams is suspected or confirmed, especially Group A streptococci in tonsillopharyngitis and erysipelas, and Treponema pallidum in early syphilis (in combination with benzathine penicillin). Its importance as a first line therapeutic agent for these indications remains high despite newer antibiotics, because the pathogen spectrum is narrow, the resistance situation is stable, and the adverse effect profile is favorable.
Mechanism of action
Phenoxymethylpenicillin, like all Beta lactam antibiotics, belongs to the class of cell wall synthesis inhibitors. It binds covalently to penicillin binding proteins (PBP), transpeptidases, which are responsible for cross linking of the murein polymer (peptidoglycan) in the bacterial cell wall. In dividing bacteria, inhibition leads to an unstable cell wall that cannot withstand osmotic pressure, resulting in lysis of the bacterial cell.
Penicillin V acts predominantly against gram positive pathogens such as streptococci (especially Streptococcus pyogenes, non resistant strains of Streptococcus pneumoniae, Viridans group), against Treponema pallidum, against Borrelia burgdorferi, and against anaerobic oral pathogens. Penicillinase producing staphylococci and gram negative pathogens (except Neisseria) are not susceptible, which explains the term narrow spectrum.
The oral bioavailability is approximately 60 percent; absorption is improved on an empty stomach. Half life approximately 30 to 60 minutes, which is why multiple daily doses are necessary. Elimination is predominantly renal in unchanged form.
Indications
- Tonsillopharyngitis caused by Group A streptococci: Standard based on Centor and McIsaac score and positive rapid test or culture
- Erysipelas and simple cellulitis: when streptococci are suspected
- Scarlet fever: in children and adults
- Early Lyme borreliosis Stage I (Erythema migrans): in children under 9 years and in pregnancy, otherwise usually doxycycline is first choice
- Rheumatic fever prophylaxis: in patients with previous rheumatic fever long term secondary prophylaxis
- Actinomycosis: long term antibiotic therapy
- Woundrose and streptococci associated skin infections
Dosage and administration
Streptococci tonsillopharyngitis adults: 1.2 to 1.5 million I.U. (equivalent to 750 to 1,000 mg) three times daily over 7 days. A shorter 5 day course is possible in some guidelines (DEGAM, IDSA) with good compliance.
Children: 50,000 to 100,000 I.U./kg/day divided into three single doses, maximum 3 million I.U./day. For infants and small children use juice or effervescent tablets.
Erysipelas: 1.5 million I.U. three to four times daily over 10 to 14 days. Borreliosis Erythema migrans: in children and pregnant women 1 to 1.5 million I.U. three times daily over 14 days.
Administration: 30 minutes before or two hours after a meal, as acid and food reduce absorption. Continue therapy consistently over the entire prescribed duration, even if symptoms improve rapidly, to avoid resistance development and streptococci complications (rheumatic fever, glomerulonephritis).
Side effects
Common: gastrointestinal complaints such as nausea, vomiting, diarrhea, abdominal pain, taste changes. Thrush (oral candidiasis) with long term therapy, especially in diabetics or immunosuppressed patients.
Occasional: allergic skin rashes such as maculopapular exanthema, pruritus, urticaria, genital candidiasis, transient increase in liver transaminases.
Serious, rare: anaphylactic reaction (incidence approximately 1 in 10,000), Stevens Johnson syndrome, renal failure with interstitial nephritis, Clostridioides difficile associated pseudomembranous colitis.
Important: Known Beta lactam allergy is an absolute contraindication. Before starting therapy, obtain allergy history and counsel on warning signs of severe reaction (shortness of breath, swelling, urticaria).
Drug interactions
- Probenecid: prolongs half life of Penicillin V by inhibiting renal tubular secretion, clinically useful for potentiating effect
- Bacteriostatic antibiotics (tetracyclines, macrolides, sulfonamides): theoretical antagonism, clinically rarely relevant in outpatient practice
- Oral anticoagulants (phenprocoumon, warfarin): possible INR elevation, check INR after 3 to 5 days
- Hormonal contraceptives: theoretical reduction in efficacy through altered gut microbiota, clinically of limited relevance; recommend temporary barrier method if additional risk present (e.g. diarrhea)
- Methotrexate: Penicillin V may reduce renal clearance of MTX, especially with high dose MTX
Special information
Pregnancy and breastfeeding: Penicillin V has been considered safe in pregnancy and breastfeeding for decades. For streptococci tonsillitis or erysipelas in pregnancy, it is the drug of first choice.
Penicillin allergy: approximately 10 percent of the population report penicillin allergy in their history, but formal allergy testing identifies only 1 to 2 percent as truly allergic. Specialist allergy evaluation is worthwhile, because avoiding Penicillin V forces use of broader antibiotics, which increase resistance risk.
Treatment adherence: the most common cause of treatment failure and complications such as rheumatic fever is premature discontinuation of Penicillin V therapy once symptoms subside. Counseling about the necessity of complete adherence is essential.
If diarrhea occurs: one to two loose stools per day are normal during antibiotic therapy. If watery, foul smelling diarrhea with abdominal cramps and fever develops, Clostridioides difficile infection should be ruled out, especially in elderly patients and after hospitalization.
You might also be interested in
- Amoxicillin, aminopenicillin with extended spectrum
- Flucloxacillin, penicillinase resistant penicillin for staphylococci
- Clarithromycin, macrolide alternative for penicillin allergy
- Clindamycin, lincosamide for penicillin allergy
- Cefuroxim, second generation cephalosporin
Frequently asked questions
Why am I getting Penicillin V and not a modern antibiotic?
Penicillin V has a very narrow spectrum of activity against exactly the pathogens expected in streptococci tonsillitis, erysipelas and borreliosis. A broader antibiotic would unnecessarily kill many other bacteria (including beneficial gut bacteria) and increase resistance risk. Narrow, targeted antibiotics are the better choice from a stewardship perspective when the pathogen is susceptible.
Can I stop therapy if I feel better after three days?
No. Premature discontinuation increases the risk of relapse and complications such as rheumatic fever, which can develop weeks after untreated streptococci tonsillitis. The full therapy duration of 7 or 10 days should be strictly adhered to.
What should I do if I have an allergic reaction?
If you develop a rash or mild itching, inform your doctor. For shortness of breath, facial swelling, anaphylaxis call emergency number 112 immediately. True penicillin allergy is a lifelong caution and should be documented in your allergy passport.
Does Penicillin V work against colds and flu?
No. Colds and flu are caused by viruses, against which antibiotics are ineffective. Antibiotic therapy without indication only promotes resistance and side effects. For sore throat without streptococci confirmation, symptomatic measures are usually sufficient.
Sources
- Gelbe Liste, Phenoxymethylpenicillin active substance profile
- DEGAM guideline sore throat
- AWMF S2k guideline borreliosis and S3 guideline tonsillitis
- BfArM, Federal Institute for Drugs and Medical Devices
Legal notices and disclaimer
The information provided on this page is for general informational purposes only and does not constitute medical advice, diagnosis or treatment recommendation. It does not replace the advice of a licensed physician or pharmacist. Medicines should only be taken according to medical prescription or pharmaceutical dispensing. All information is based on expert information and recognized scientific sources published at the time of creation; the current product information of the manufacturer is always authoritative. Sanoliste accepts no liability for completeness, accuracy or timeliness of the information presented. In a medical emergency, call emergency number 112.